Biotech Company Cara Therapeutics (CARA) Up 15%

Despite the sea of red in U.S. markets today, one stock that has been showing stellar gain is biotech company Cara Therapeutics (CARA). Cara, a biotech that has been developing treatments for itchiness, rose 12.6% in pre-market trade Wednesday after the company released studies that dialysis...
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.